Clinical Psychopharmacology · Paper A
Pregabalin and gabapentin
Pregabalin and gabapentin matter because, despite names that sound related to GABAThe brain's main calming (inhibitory) chemical messenger, boosted by benzodiazepines and alcohol.Read more → (gamma-aminobutyric acid, the brain's main inhibitory neurotransmitterA chemical messenger that nerve cells release to signal to the next cell.Read more →), they do not act on GABA receptors at all. Both bind the alpha-2-delta subunit of voltage-gated calcium channels, reducing the release of excitatory neurotransmitters from overactive neurons. For example, imagine a patient assuming gabapentin works like a benzodiazepine because both calm anxiety: in fact their mechanisms are completely different, even though the clinical effect can look similar. This distinction matters because it explains why they are used for neuropathic pain (pain from damaged nerves) and generalised anxiety disorder, not for psychosis or seizures alone.
By binding the alpha-2-delta subunit of calcium channels, pregabalin and gabapentin reduce calcium influx into the nerve terminal, which reduces release of excitatory neurotransmittersA chemical messenger that nerve cells release to signal to the next cell.Read more → such as glutamate. This calms overactive nerve signalling, which is why both drugs help neuropathic pain and generalised anxiety disorder (GADGeneralised anxiety disorder, persistent, hard-to-control worry across many areas of life.Read more →), and why gabapentin is also used for some seizure disorders. Picture a patient with both diabetic neuropathy and generalised anxiety disorder: a single drug, pregabalin, can be chosen to treat both problems. In practice, clinicians must still monitor closely, because both drugs carry a real risk of misuse and dependence, and combining either with an opioid dangerously increases the risk of fatal respiratory depression (slowed, inadequate breathing).